322 related articles for article (PubMed ID: 15628970)
1. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members.
Mahoney WM; Hong JH; Yaffe MB; Farrance IK
Biochem J; 2005 May; 388(Pt 1):217-25. PubMed ID: 15628970
[TBL] [Abstract][Full Text] [Related]
2. Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes.
Chen HH; Mullett SJ; Stewart AF
J Biol Chem; 2004 Jul; 279(29):30800-6. PubMed ID: 15140898
[TBL] [Abstract][Full Text] [Related]
3. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
4. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor RTEF-1 mediates alpha1-adrenergic reactivation of the fetal gene program in cardiac myocytes.
Stewart AF; Suzow J; Kubota T; Ueyama T; Chen HH
Circ Res; 1998 Jul; 83(1):43-9. PubMed ID: 9670917
[TBL] [Abstract][Full Text] [Related]
6. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
7. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm.
Vassilev A; Kaneko KJ; Shu H; Zhao Y; DePamphilis ML
Genes Dev; 2001 May; 15(10):1229-41. PubMed ID: 11358867
[TBL] [Abstract][Full Text] [Related]
8. The role of transcription enhancer factor-1 (TEF-1) related proteins in the formation of M-CAT binding complexes in muscle and non-muscle tissues.
Farrance IK; Ordahl CP
J Biol Chem; 1996 Apr; 271(14):8266-74. PubMed ID: 8626521
[TBL] [Abstract][Full Text] [Related]
9. Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in alpha 1-adrenergic agonist-stimulated cardiac myocytes.
Maeda T; Mazzulli JR; Farrance IK; Stewart AF
J Biol Chem; 2002 Jul; 277(27):24346-52. PubMed ID: 11986313
[TBL] [Abstract][Full Text] [Related]
10. Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation.
Maeda T; Chapman DL; Stewart AF
J Biol Chem; 2002 Dec; 277(50):48889-98. PubMed ID: 12376544
[TBL] [Abstract][Full Text] [Related]
11. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters.
Maeda T; Gupta MP; Stewart AF
Biochem Biophys Res Commun; 2002 Jun; 294(4):791-7. PubMed ID: 12061776
[TBL] [Abstract][Full Text] [Related]
12. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C.
Park KS; Whitsett JA; Di Palma T; Hong JH; Yaffe MB; Zannini M
J Biol Chem; 2004 Apr; 279(17):17384-90. PubMed ID: 14970209
[TBL] [Abstract][Full Text] [Related]
13. Identification of the functional domain in the transcription factor RTEF-1 that mediates alpha 1-adrenergic signaling in hypertrophied cardiac myocytes.
Ueyama T; Zhu C; Valenzuela YM; Suzow JG; Stewart AF
J Biol Chem; 2000 Jun; 275(23):17476-80. PubMed ID: 10764782
[TBL] [Abstract][Full Text] [Related]
14. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
15. AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells.
Lucci V; Di Palma T; D'Ambrosio C; Scaloni A; Zannini M
Gene; 2013 Oct; 529(2):300-6. PubMed ID: 23911299
[TBL] [Abstract][Full Text] [Related]
16. TAZ and YAP are frequently activated oncoproteins in sarcomas.
Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
[TBL] [Abstract][Full Text] [Related]
17. Two MCAT elements of the SM alpha-actin promoter function differentially in SM vs. non-SM cells.
Swartz EA; Johnson AD; Owens GK
Am J Physiol; 1998 Aug; 275(2):C608-18. PubMed ID: 9688616
[TBL] [Abstract][Full Text] [Related]
18. Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: evidence for an ancient multigene family.
Stewart AF; Richard CW; Suzow J; Stephan D; Weremowicz S; Morton CC; Adra CN
Genomics; 1996 Oct; 37(1):68-76. PubMed ID: 8921372
[TBL] [Abstract][Full Text] [Related]
19. The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.
Santucci M; Vignudelli T; Ferrari S; Mor M; Scalvini L; Bolognesi ML; Uliassi E; Costi MP
J Med Chem; 2015 Jun; 58(12):4857-73. PubMed ID: 25719868
[TBL] [Abstract][Full Text] [Related]
20. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
